Trexquant Investment LP raised its stake in EverQuote, Inc. (NASDAQ:EVER - Free Report) by 77.2% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 265,671 shares of the company's stock after acquiring an additional 115,777 shares during the period. Trexquant Investment LP owned approximately 0.75% of EverQuote worth $5,311,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also made changes to their positions in EVER. Geode Capital Management LLC grew its holdings in EverQuote by 0.9% during the 4th quarter. Geode Capital Management LLC now owns 600,365 shares of the company's stock valued at $12,004,000 after buying an additional 5,210 shares in the last quarter. Franklin Resources Inc. increased its position in EverQuote by 86.1% in the fourth quarter. Franklin Resources Inc. now owns 109,372 shares of the company's stock worth $2,186,000 after purchasing an additional 50,591 shares during the last quarter. Alliancebernstein L.P. raised its stake in EverQuote by 308.0% during the fourth quarter. Alliancebernstein L.P. now owns 108,890 shares of the company's stock valued at $2,177,000 after purchasing an additional 82,200 shares in the last quarter. Schroder Investment Management Group bought a new position in EverQuote during the fourth quarter valued at $2,657,000. Finally, Arrowstreet Capital Limited Partnership lifted its position in EverQuote by 32.8% during the fourth quarter. Arrowstreet Capital Limited Partnership now owns 654,152 shares of the company's stock valued at $13,076,000 after purchasing an additional 161,426 shares during the last quarter. Institutional investors own 91.54% of the company's stock.
Analyst Ratings Changes
Several brokerages have recently issued reports on EVER. Raymond James upgraded shares of EverQuote from an "outperform" rating to a "strong-buy" rating and set a $35.00 target price on the stock in a research report on Thursday, December 26th. Needham & Company LLC upped their price objective on EverQuote from $30.00 to $38.00 and gave the company a "buy" rating in a research report on Tuesday, February 25th. Canaccord Genuity Group dropped their target price on EverQuote from $35.00 to $30.00 and set a "buy" rating for the company in a report on Monday, February 24th. Finally, JPMorgan Chase & Co. increased their price target on EverQuote from $25.00 to $29.00 and gave the company an "overweight" rating in a report on Tuesday, February 25th. Five research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, the company presently has a consensus rating of "Buy" and a consensus target price of $32.33.
Check Out Our Latest Analysis on EverQuote
Insider Buying and Selling
In other news, Director John L. Shields sold 2,000 shares of EverQuote stock in a transaction on Monday, January 27th. The stock was sold at an average price of $20.00, for a total value of $40,000.00. Following the transaction, the director now directly owns 28,515 shares in the company, valued at approximately $570,300. This trade represents a 6.55 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CAO Jon Ayotte sold 7,647 shares of the company's stock in a transaction on Thursday, February 27th. The stock was sold at an average price of $25.72, for a total value of $196,680.84. Following the sale, the chief accounting officer now owns 58,045 shares of the company's stock, valued at $1,492,917.40. This trade represents a 11.64 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 180,857 shares of company stock valued at $4,992,367 over the last quarter. 29.79% of the stock is owned by corporate insiders.
EverQuote Stock Down 1.8 %
EVER traded down $0.38 during trading hours on Thursday, reaching $21.28. 189,996 shares of the company's stock traded hands, compared to its average volume of 539,918. The firm has a 50-day moving average price of $24.35 and a 200 day moving average price of $20.90. EverQuote, Inc. has a 52-week low of $16.63 and a 52-week high of $30.03. The firm has a market capitalization of $760.21 million, a PE ratio of 62.26 and a beta of 0.77.
EverQuote (NASDAQ:EVER - Get Free Report) last posted its quarterly earnings results on Monday, February 24th. The company reported $0.33 EPS for the quarter, topping the consensus estimate of $0.15 by $0.18. The company had revenue of $147.46 million for the quarter, compared to the consensus estimate of $133.83 million. EverQuote had a net margin of 3.31% and a return on equity of 13.94%. Equities analysts predict that EverQuote, Inc. will post 0.72 EPS for the current fiscal year.
EverQuote Profile
(
Free Report)
EverQuote, Inc operates an online marketplace for insurance shopping in the United States. The company offers auto, home and renters, and life insurance. The company serves carriers and agents, as well as indirect distributors. The company was formerly known as AdHarmonics, Inc, and changed its name to EverQuote, Inc in November 2014.
Further Reading

Before you consider EverQuote, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and EverQuote wasn't on the list.
While EverQuote currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.